The SOD1-G93A transgenic mouse model, which overexpresses a mutant form of superoxide dismutase 1 (SOD1), is commonly used to study ALS and displays clinical symptoms at 70–140 days of age (Ly et al., 2020). The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.